MedTrace Logo

Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery

NCT04153383 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-09-28

No results posted yet for this study

Summary

The purpose of this study is to analyze the changes in cardiac performance before and after milrinone administration in order to find out whether milrinone improves LV performance in patients undergoing coronary artery bypass surgery.

Conditions

  • Ischemic Heart Disease

Interventions

DRUG

Milrinone Injection

giving IV milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/min IV

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04153383 on ClinicalTrials.gov